Comparison of two modes of vitamin B₁₂supplementation on neuroconduction and cognitive function among older people living in Santiago, Chile: a cluster randomized controlled trial. a study protocol [ISRCTN 02694183]

• Main Authors: Brito Alex, Hertrampf Eva, Lavados Manuel, Verdugo Renato, Castillo José, Lera Lydia, Albala Cecilia, Sánchez Hugo, Allen Lindsay, Uauy Ricardo
• Format: Article
• Language: English
• Published: BMC 2011-09-01
• Series: Nutrition Journal
• Subjects: cobalamin; vitamin B12; cyanocobalamin; elderly; neurophysiology; cognitive disorders; nerve conduction; cluster randomized controlled trial; public health; Chile
• Online Access: http://www.nutritionj.com/content/10/1/100

<p>Abstract</p> <p>Background</p> <p>Older people have a high risk of vitamin B₁₂deficiency; this can lead to varying degrees of cognitive and neurological impairment. CBL deficiency may present as macrocytic anemia, subacute combined degeneration of the spinal cord, or as neuropathy, but is often asymptomatic in older people. Less is known about subclinical vitamin B12 deficiency and concurrent neuroconduction and cognitive impairment. A Programme of Complementary Feeding for the Older Population (PACAM) in Chile delivers 2 complementary fortified foods that provide approximately 1.4 μg/day of vitamin B12 (2.4 μg/day elderly RDA). The aim of the present study is to assess whether supplementation with vitamin B12 will improve neuroconduction and cognitive function in older people who have biochemical evidence of vitamin B12 insufficiency in the absence of clinical deficiency.</p> <p>Methods</p> <p>We designed a cluster double-blind placebo-controlled trial involving community dwelling people aged 70-79 living in Santiago, Chile. We randomized 15 clusters (health centers) involving 300 people (20 per cluster). Each cluster will be randomly assigned to one of three arms: a) a 1 mg vitamin B12 pill taken daily and a routine PACAM food; b) a placebo pill and the milk-PACAM food fortified to provide 1 mg of vitamin B12; c) the routine PACAM food and a placebo pill.</p> <p>The study has been designed as an 18 month follow up period. The primary outcomes assessed at baseline, 4, 9 and 18 months will be: serum levels of vitamin B12, neuroconduction and cognitive function.</p> <p>Conclusions</p> <p>In view of the high prevalence of vitamin B12 deficiency in later life, the present study has potential public health interest because since it will measure the impact of the existing program of complementary feeding as compared to two options that provide higher vitamin B12 intakes that might potentially may contribute in preserving neurophysiologic and cognitive function and thus improve quality of life for older people in Chile.</p> <p>Trial registration</p> <p>ISRCTN: <a href="http://www.controlled-trials.com/ISRCTN02694183">ISRCTN02694183</a></p>